Shares of Cybin Inc. (OTCMKTS:CLXPF – Get Free Report) hit a new 52-week high on Monday . The stock traded as high as $9.84 and last traded at $9.82, with a volume of 111505 shares trading hands. The stock had previously closed at $9.78.
Cybin Stock Down 1.4 %
The firm has a market capitalization of $1.44 billion and a PE ratio of -40.33. The firm’s 50 day moving average price is $3.52 and its two-hundred day moving average price is $1.45.
About Cybin
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
Read More
- Five stocks we like better than Cybin
- How to Invest in the FAANG Stocks
- Taiwan Semiconductor Stock: Buy Now or Wait for Earnings?
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Citigroup Faces Growing Troubles: Could the Industry Be at Risk?
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
